Lumia Health, Inc.

Based in the US, Lumia Health, Inc. specializes in innovative wearable technology that monitors blood flow, enhancing wellness for users managing chronic symptoms related to dysautonomia and similar conditions. Lumia Health, Inc. was founded in 2020 in Allston, US.

The company focuses on developing wearable technology to track blood flow through its flagship product, the Lumia earpiece. In November 2025, Lumia Health raised USD 7 mn in funding from J2 Ventures and BonAngels Venture Partners, which will support their expansion in production and research collaborations. The company has completed two deals to date, with the most recent funding round marking the total amount raised at USD 7 mn. Lumia Health specializes in innovative wearable technology designed to optimize blood flow to the head, primarily through their flagship product, the Lumia earpiece.

This device is engineered to track and monitor blood flow using proprietary sensors, offering users real-time insights into how various activities, postures, and lifestyle choices affect their blood circulation. Targeting individuals aged 13 and older, particularly those managing chronic symptoms related to dysautonomia and other conditions that impact blood flow, the Lumia earpiece aims to enhance overall wellness and cognitive function. The device, which fits comfortably in the left ear, integrates seamlessly with an accompanying iPhone app that enables users to tag daily activities, meals, and medications, providing personalized feedback on factors that influence blood flow. Currently, Lumia Health's offerings are primarily available within the fifty United States, with plans for potential international expansion in the future.

Lumia Health operates on a subscription-based model through its Lumia Edge Access Program, which is essential for users to gain full functionality from their wearable devices. This program includes mobile app access, continuous feature updates, free hardware upgrades, and a lifetime warranty on the Lumia earpiece. The core product, Lumia, retails at USD 399, with additional options available that enhance the aesthetic and functional experience. Customers can also use Health Savings Account (HSA) or Flexible Spending Account (FSA) cards for purchases, making it accessible for a broad client base interested in improving their health and managing symptoms associated with poor blood flow.

The structure of transactions is primarily direct-to-consumer, facilitating a streamlined purchasing experience that aligns with the company's focus on personal health optimization. In November 2025, Lumia Health, Inc. raised USD 7 mn in venture funding to expand production of its blood flow-tracking earrings and initiate research collaborations with leading institutions. The company is focused on launching new product iterations in the wearable tech space and aims to enhance its market presence, potentially expanding into international markets beyond the United States.